
Futibatinib Now Available in Italy for Cholangiocarcinoma Treatment, Announces Taiho Oncology Europe
Futibatinib Now Available in Italy for Cholangiocarcinoma Treatment, Announces Taiho Oncology Europe Taiho Oncology Europe GmbH has announced the availability of futibatinib in Italy for the treatment of cholangiocarcinoma (CCA),…











